证券记录 · 已归档季度
HOLX
Hologic, Inc. · Healthcare · Medical - Instruments & Supplies
15被追踪持有人
—Δ持有人
21.25M持有股份
$1.58B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 150 | -11 | 142.41M | $10.76B | — | −12 |
| Q4 2025 | 160 | -1 | 162.64M | $12.11B | +3 | −3 |
| Q3 2025 | 23 | 0 | 82.82M | $5.59B | +1 | −2 |
| Q2 2025 | 21 | +4 | 78.04M | $5.08B | +4 | — |
| Q1 2025 | 14 | -1 | 24.06M | $1.49B | — | −1 |
| Q4 2024 | 15 | 0 | 25.76M | $1.86B | — | — |
| Q3 2024 | 14 | -1 | 17.19M | $1.40B | — | −1 |
| Q2 2024 | 15 | — | 21.25M | $1.58B | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.88M | — | $436.31M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.88M | — | $436.31M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 5.57M | — | $412.75M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.57M | — | $412.75M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 2.54M | — | $188.88M | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (被动) | 2.42M | — | $180.03M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.19M | — | $88.63M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 1.19M | — | $88.63M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 1.19M | — | $88.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.19M | — | $88.63M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 1.09M | — | $80.78M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 806.34K | — | $59.87M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 806.34K | — | $59.87M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 565.96K | — | $42.02M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 565.96K | — | $42.02M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 565.96K | — | $42.02M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 531.00K | — | $39.43M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 531.00K | — | $39.43M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 317.33K | — | $23.56M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 221.29K | — | $16.43M | 0.2% | n/c | 1 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 54.39K | — | $4.04M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Millennium Management ✦ | 45.42K | — | $3.37M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 8.79K | — | $652,764 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 2.38K | — | $176,715 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 699 持有人, 212.67M 股份, $15.33B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据